NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Tactile Systems Technology, Inc. (TCMD) Stock Analysis

Tactile Systems Technology, Inc. (TCMD) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

TCMD

$21.87

−$0.14 (−0.64%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare TCMD with… →

TCMD Key Statistics

As of Sep 4, 2026
Trading
Open
$21.76
Previous Close
$22.01
Day's Range
21.62–22.26
52-Week Range
13.14–37.77
Volume
197.90K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.79
Valuation
Market Cap
$495.41M
P/E Ratio
20.63
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
15.03
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
17.79
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.41
EPS (ttm)Profit attributable to each share over the last twelve months.
1.06
Financials (FY)
Revenue (FY)
$329.52M+12.47%
Net Income (FY)
$19.09M+12.54%
Profit marginThe share of revenue left as profit after all costs and taxes.
7.10%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
22.65M
1-Year Return
+62.97%
Dividend and dates
Earnings Date
November 2, 2026
Avg Volume
289.93K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

TCMD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−24.59%
2025+69.29%
2024+19.79%
2023+24.56%
2022−39.67%
2021−57.65%
2020−33.43%
2019+48.21%
2018+57.18%
2017+76.60%
2016 (partial year)+18.74%

As of September 4, 2026.

TCMD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$329.52M$19.09M5.8%
2024$292.98M$16.96M5.8%
2023$274.42M$28.52M10.4%
2022$246.79M−$17.87M−7.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$329.52M$250.15M$29.28M$19.09M5.8%
2024$292.98M$216.69M$22.18M$16.96M5.8%
2023$274.42M$195.13M$18.04M$28.52M10.4%
2022$246.79M$175.98M−$12.76M−$17.87M−7.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

TCMD Valuation vs Medical Devices Median

Median of 151 stocks
MetricTCMDMedical Devices medianvs median
P/E20.6326.8023% below
P/S ratio1.412.9852% below
Profit margin7.10%−1.69%8.8 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Tactile Systems Technology, Inc. (TCMD) is capitalised at $495.41M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 1,086 employees.

The most recent close on file for TCMD is $21.87, dated September 4, 2026. That is −$0.14 (−0.64%) against the previous close. The 52-week range on file runs from $13.14 to $37.77. The latest close sits 66.44% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $329.52M. Against the prior fiscal year total of $292.98M, that is a change of +12.47%. The same year closed with net income of $19.09M. That is +12.54% against the prior fiscal year. The reported profit margin is 7.1%. That is 8.8 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 1.06.

Across the 4 fiscal years on file, revenue moves from $246.79M in 2022 to $329.52M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 20.63. That is 23.02% below the Medical Devices median of 26.8. On forward earnings the ratio is 15.03. The PEG ratio, which sets the P/E against expected earnings growth, reads 17.79. Measured against sales, the shares trade at 1.41 times revenue. On price-to-sales that is 52.48% below the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.79. Daily returns over the trailing 10 years annualize to a volatility of 56.57%. Over the trailing twelve months the price has returned +62.97%. Measured over 10 years, that is +3.93% a year compounded.

Growth & Income

No dividend is on file for TCMD.

The strongest complete calendar year on file is 2017 at +76.60%; the weakest is 2021 at −57.65%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the price is −24.59%.

Peer Comparison

Tactile Systems Technology, Inc. (TCMD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Tactile Systems Technology, Inc. TCMD $495.41M 20.6
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Tactile Systems Technology, Inc. trades at a P/E of 20.6.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Visit website →